AzTrials
AzTrials

BurnoutNCT06582927

Mindfulness Training for First Responders

A study testing Mindfulness-Based Attention Training (MBAT) in people with Burnout, run by University of Miami at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study evaluates the efficacy of Mindfulness-Based Attention Training on measures targeting cognitive abilities and emotional well-being in first responders. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Burnout
What is being tested?
Mindfulness-Based Attention Training (MBAT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
87 participants
Where
1 siteUnited States
Study dates
22 Jul 2025to 10 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Individuals who are between 18 and 75 years of age
  • Individuals who are fluent English speakers
  • Individuals who are able to adequately and independently use electronic devices, such as a laptop, computer, or tablet, and have Internet connection
  • Individuals who are willing and able to consent to participate in the study
  • Participants in all phases of the study must be individuals who are affiliated with the Los Angeles County Fire Department peer support group.

Who cannot join

  • 1. Individuals with an active and untreated mental health issue and/or hospitalization for psychological/mental health issues within the past month

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Miami

    Coral Gables, Florida, 33146

Other trials in United States

About this study

The present study evaluates the efficacy of Mindfulness-Based Attention Training on measures targeting cognitive abilities and emotional well-being in first responders.

Conditions
Burnout
Being tested
Mindfulness-Based Attention Training (MBAT)
Medical subject headings
Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-Based Attention Training (MBAT)Behavioural

    MBAT is an evidence-based 8-hour mindfulness program that comprises 4 central topics and associated practices. The concentration topic introduces participants to mindfulness "basics," including discussion of focused attention and mind wandering. The body awareness theme involves the cultivation of greater self-awareness, and the development of equanimity. The open monitoring theme emphasizes awareness of and receptivity to changing experiences and moments of uncertainty. The theme of connection addresses leadership and group cohesion, and the cultivation of kindness and connection with others.

    The course content and materials in the present study will entail the foundational MBAT curriculum and other related content delivered virtually over Zoom but will consist of 8, 1-hour sessions delivered across 8 consecutive weeks.

Study groups in NCT06582927
Study groupRoleWhat they receive
Mindfulness Training Group AExperimentalParticipants in this group will receive mindfulness training in up to 8 weeks.
Receives: Behavioral: Mindfulness-Based Attention Training (MBAT)
Wait-list condition Group BActive comparatorParticipants in this group will be on a waiting list to receive the identical intervention as the experimental group at a later time. Total participation in the mindfulness training will be 8 weeks
Receives: Behavioral: Mindfulness-Based Attention Training (MBAT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in sustained attention

    The Sustained Attention to Response Task (SART) is used to assess attentional performance and mind wandering (i.e., off-task thinking which is typically self-generated and compromises the performance of the task at hand). The task uses a continuous performance paradigm involving button presses to frequently presented nontargets (numbers 0, 1, 2, 4, 5, 6, 7, 8, and 9) but requires the participants to withhold their motor response to the infrequent target (number 3). Withholding responses only to infrequent targets encourages a pre-potent response and mind wandering. Real-time subjective experience of mind wandering during SART is assessed through experience-sampling probes randomly presented throughout the task.

    Measured: Baseline to week 11

  2. Change in resilience

    Resilience is assessed via the 6-item Brief Resilience Scale (BRS). The scores range from 6 to 30, with a higher score indicating a higher level of resilience.

    Measured: Baseline to week 11

Secondary outcomes (5)
  1. Change in decentering

    Decentering is assessed via the 11-item decentering sub-scale of the experience questionnaire (EQ-D). The decentering score ranges from 1 to 55, with a higher score indicating a higher level of decentering.

    Measured: Baseline to week 11

  2. Change in positive affect

    Positive Affect is assessed with the 5-item positive sub-scale from Positive and Negative Affect Schedule (PANAS). PANAS Positive has a range of scores from 5 to 25, with a higher score indicating a higher positive mood.

    Measured: Baseline to week 11

  3. Change in negative affect

    Negative Affect is assessed with the 5-item negative sub-scale from Positive and Negative Affect Schedule (PANAS-10). PANAS Negative has a range of scores from 5 to 25, with a higher score indicating a higher negative mood.

    Measured: Baseline to week 11

  4. Change in perceived stress

    Perceived stress is assessed with the 4-item Perceived Stress Scale (PSS-4). PSS-4 has a range of scores from 0 to 16, with a higher score indicating a higher level of perceived stress.

    Measured: Baseline to week 11

  5. Change in burnout

    Burnout is assessed with the 12-item Burnout Assessment Tool (BAT-12). BAT-12 has a range of score from 1 to 5, with a higher score indicated a higher level of burnout.

    Measured: Baseline to week 11

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2024
  2. Study start22 Jul 2025
  3. Primary completion10 Apr 2026
  4. Study completion10 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
87 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06582927
Sponsor's protocol ID
20240877
Status last verified
May 2026
First submitted
30 Aug 2024
Last updated
15 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness-Based Attention Training (MBAT) in people with Burnout, run by University of Miami at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in sustained attention (time frame: Baseline to week 11). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in